TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 40.787
NA - Nord America 37.787
AS - Asia 20.079
SA - Sud America 3.563
Continente sconosciuto - Info sul continente non disponibili 557
AF - Africa 480
OC - Oceania 87
AN - Antartide 1
Totale 103.341
Nazione #
US - Stati Uniti d'America 36.067
NL - Olanda 15.152
SG - Singapore 7.234
IT - Italia 6.661
RU - Federazione Russa 5.437
CN - Cina 5.078
GB - Regno Unito 4.683
VN - Vietnam 2.850
BR - Brasile 2.835
DE - Germania 2.388
UA - Ucraina 1.996
CA - Canada 1.255
DK - Danimarca 1.241
HK - Hong Kong 1.142
KR - Corea 1.075
FR - Francia 880
BD - Bangladesh 802
SE - Svezia 564
IN - India 460
FI - Finlandia 408
IE - Irlanda 349
PL - Polonia 313
AR - Argentina 268
MX - Messico 245
ES - Italia 172
ZA - Sudafrica 170
ID - Indonesia 168
TR - Turchia 167
JP - Giappone 165
IQ - Iraq 151
EC - Ecuador 133
EU - Europa 126
IL - Israele 101
PK - Pakistan 89
AT - Austria 86
CO - Colombia 82
PH - Filippine 76
AU - Australia 75
VE - Venezuela 72
MA - Marocco 66
MY - Malesia 64
CH - Svizzera 63
BE - Belgio 62
SA - Arabia Saudita 61
UZ - Uzbekistan 59
LT - Lituania 56
CL - Cile 50
PE - Perù 47
JM - Giamaica 46
PT - Portogallo 41
JO - Giordania 40
AE - Emirati Arabi Uniti 39
PY - Paraguay 38
EG - Egitto 36
CR - Costa Rica 34
TN - Tunisia 34
KE - Kenya 32
TW - Taiwan 32
RO - Romania 30
TH - Thailandia 30
IR - Iran 25
AZ - Azerbaigian 24
BG - Bulgaria 23
HN - Honduras 23
NP - Nepal 23
AL - Albania 21
DO - Repubblica Dominicana 21
ET - Etiopia 21
SK - Slovacchia (Repubblica Slovacca) 20
DZ - Algeria 19
KZ - Kazakistan 18
CZ - Repubblica Ceca 17
NI - Nicaragua 17
SN - Senegal 17
UY - Uruguay 17
GR - Grecia 16
TT - Trinidad e Tobago 16
HU - Ungheria 15
NG - Nigeria 14
RS - Serbia 14
BO - Bolivia 13
CI - Costa d'Avorio 13
CY - Cipro 13
GT - Guatemala 13
HR - Croazia 13
ML - Mali 13
LV - Lettonia 12
OM - Oman 12
PA - Panama 12
PS - Palestinian Territory 12
BA - Bosnia-Erzegovina 11
NZ - Nuova Zelanda 11
AO - Angola 10
LB - Libano 10
BY - Bielorussia 8
GE - Georgia 8
MD - Moldavia 8
SI - Slovenia 8
GH - Ghana 7
KG - Kirghizistan 7
Totale 102.771
Città #
Amsterdam 14.944
Dallas 6.225
Singapore 3.775
Southend 3.055
Ashburn 2.510
San Jose 2.215
Beijing 2.122
Chandler 2.063
Woodbridge 1.736
Houston 1.579
Ann Arbor 1.350
Council Bluffs 1.181
San Mateo 1.164
Hong Kong 1.094
Milan 1.020
Moscow 956
Jacksonville 950
Dearborn 841
Daejeon 815
Fairfield 780
The Dalles 761
Ho Chi Minh City 743
Rome 659
Falls Church 629
Los Angeles 617
Cambridge 603
Wilmington 576
Pisa 573
New York 549
Hanoi 492
Seattle 464
Hefei 408
Dong Ket 397
Lauterbourg 394
Santa Clara 389
Stevenage 379
Boardman 375
Portsmouth 357
Montréal 339
Lawrence 325
São Paulo 324
Dublin 321
Warsaw 267
Munich 264
Buffalo 253
Seoul 248
Brooklyn 237
Beauharnois 228
Fremont 191
Columbus 187
Orem 186
Ottawa 178
Montreal 171
Figino 153
Redwood City 147
Chicago 141
London 136
Denver 134
Chennai 130
Old Bridge 130
Salerno 130
Atlanta 128
Phoenix 128
Tokyo 127
Mexico City 119
Florence 115
Stockholm 112
Johannesburg 111
Toronto 111
Turin 110
Da Nang 104
San Diego 104
Helsinki 102
Poplar 100
Bologna 93
Mcallen 91
Frankfurt am Main 86
Rio de Janeiro 86
Naples 84
Haiphong 82
San Francisco 78
Tel Aviv 77
Manchester 73
Nuremberg 71
Boston 68
Guangzhou 65
Ankara 62
Norwalk 59
Wuxi 57
Brasília 53
Serra 53
Tashkent 53
Biên Hòa 52
Belo Horizonte 51
Guayaquil 51
Mumbai 50
Palermo 48
Shanghai 46
Baghdad 45
Paris 45
Totale 67.710
Nome #
L’Economia digitale e il settore assicurativo 2.123
The interaction of public and private systems in healthcare provision 2.051
Il Costo Sociale della Malattia di Alzheimer 2.015
Il governo delle tecnologie per un ammodernamento del Sistema Sanitario 2.012
Il Costo Sociale dell’Emicrania 2.011
La qualità della vita di soggetti anziani nelle grandi città e nei piccoli paesi: uno studio comparato sui bisogni dei cittadini in Italia ed in Giappone 2.008
L’E-Commerce. Le Nuove Frontiere della Distribuzione Assicurativa 2.003
Prevenzione delle cadute da incidente domestico negli anziani 2.002
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 892
Nutri-Score and Food Perception: Insights from an Italian Study 797
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 589
On Robots and Insurance 579
The Effect of using Serifs in Brand Names on Luxury Perception 542
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 521
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 516
A new organizational integrated home-care model: An Italian pilot study 515
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 464
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 456
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 450
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 421
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 419
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 413
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 401
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 397
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 392
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 382
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 378
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 372
Marketing per la Sanità. Logiche e strumenti 353
Early assessment of neuro-rehabilitation technology: a case study 350
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 347
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 344
Health technology assessment. Evaluation of biomedical innovative technologies 340
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 339
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 336
A Pitcure of Private Health Insurance Policyholders in Italy 336
How colour saturation accelerates purchase behaviour, and influences food choice: 335
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 334
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 331
Cost analysis of the robotic surgery in Italy 329
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 326
Early assessment of neuro-rehabilitation technology 325
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 323
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 323
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 321
Early assessment of neuro – rehabilitation technology: a case study 320
A systematic literature review of the economic impact of ankylosing spondylitis 319
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 319
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 315
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 314
An economic evaluation of different procedures in bariatric surgery 313
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 313
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 313
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 310
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 308
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 307
Is EEG Suitable for Marketing Research? A Systematic Review 307
Economia e gestione delle imprese di assicurazione 305
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 304
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 303
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 300
Topic modeling and user network analysis on twitter during world lupus awareness day 300
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 299
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 299
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 298
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 297
A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools 297
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 296
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 295
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 294
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 294
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 293
A registry for the collection of data in cochlear implant patients 293
Innovation in rehabilitation technology 292
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 292
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 290
Natural and man-made disasters: challenges and international perspectives for insurance 288
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 287
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 287
Economic impact of drug addiction interventions in adult population: The Peru case 283
Late chronotypes, late mealtimes. Chrononutrition and sleep habits during the COVID-19 lockdown in Italy 283
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 282
Assessing the value of the use of diagnostic technology: trade offs for GPs 280
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 278
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 278
2023 update on Italian guidelines for the treatment of type 2 diabetes 276
Adherence to treatment in Behçet's syndrome: a multi-faceted issue 276
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 275
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 275
The quality of life of patients treated with robotic versus traditional surgery: results from an Italian observational multicenter study 274
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 274
Evidence-gathering across industry and academia on early Health Technology Assessment (HTA) of medical devices: survey design and piloting 271
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 270
Dentro, attraverso, oltre la crisi: il caso El.En 269
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 269
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 269
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic 268
Il Governo della Sanità 268
Sleep quality mediates the effect of chronotype on resilience in the time of COVID-19 268
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 267
Totale 47.827
Categoria #
all - tutte 453.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 453.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.492 0 871 157 297 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202652.246 1.956 5.594 4.216 4.334 4.131 2.434 4.581 1.615 16.823 2.381 1.648 2.533
2026/20272.056 809 1.247 0 0 0 0 0 0 0 0 0 0
Totale 103.341